Carbonic anhydrase is a metalloenzyme that catalyzes the reversible conversion of CO2 to bicarbonate, anessential metabolic component used by the malaria parasites for de novo synthesis of pyrimidines and theexflagelation of gametocytes inside the mosquito vector. Carbonic anhydrase is involved in the transportof bicarbonate. This enzyme participates in transport of bicarbonate inside and outside the cells to avoidan imbalance in the system CO2/HCO3- and alteration of pH in the interior of the cell as well as in theintercellular space. Therefore, inhibition of this enzyme either in the parasite or the insect vector, couldlead to a decrease in replication and to the detriment and/or death of the parasite. Given the importance ofcarbonic anhydrase in the metabolism, development and survival of Plasmodium, it could be postulatedthat carbonic anhydrase inhibitors are both a therapeutic and a blocking transmission alternative. Previousstudies have demonstrated the in vitro anti-Plasmodium activity of some inhibitors. However, it isnecessary to determine their effectiveness to confirm its usefulness in the treatment or blocking malariatransmission and the mechanism by which these inhibitors are able to affect the development of theparasite in the mosquito vector. In this paper we present a review about the role of carbonic anhydrase inPlasmodium spp and using some specific inhibitors as a strategy for malaria treatment and transmissionblocking strategy. Articles published in the past 59 years identified from bibliographic database (PubMedand ScienceDirect) and papers collected by the authors were included.